Warning letter
General Medical Company: warning letter of Jun 2, 2016
FDA warning letter 487535 · Los Angeles District Office
Key facts
| Reference number | 487535 |
|---|---|
| Company | General Medical Company |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Jun 2, 2016 |
| Posted date | Jun 28, 2016 |
| Issuing office | Los Angeles District Office |
| Product type | Tobacco |
| CFR sections cited | 807.81(a)(3)(i), 803, 801.109(a)(2), 801.109(b)(1), 820 |
| Inspection city | Jacksonville |
| Inspection ZIP | 32256 |
| Inspection start date | Oct 21, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: